Showing results (71-80 of 116) with videos related to
Sort By:
Pageof 12
Cold Spring Harbor Molecular Case Studies|June 5, 2019
Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumorLaura M Williamson, Michael Steel, Jasleen K Grewal, et al.Communications Biology|July 4, 2025
Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasisPaul C McDonald, James T Topham, Shannon Awrey, et al.Journal of Cancer Research and Clinical Oncology|February 21, 2019
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progressionMartin Schuler, Eng-Huat Tan, Kenneth O'Byrne, et al.Plos One|March 24, 2015
Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencingBrandon S Sheffield, Anna V Tinker, Yaoqing Shen, et al.Cold Spring Harbor Molecular Case Studies|April 4, 2018
Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-makingManik Chahal, Erin Pleasance, Jasleen Grewal, et al.Genome Medicine|November 23, 2024
Mapping in silico genetic networks of the KMT2D tumour suppressor gene to uncover novel functional associations and cancer cell vulnerabilitiesYuka Takemon, Erin D Pleasance, Alessia Gagliardi, et al.Cancer|November 27, 2019
Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancerVassiliki A Papadimitrakopoulou, Ji-Youn Han, Myung-Ju Ahn, et al.JCO Precision Oncology|January 20, 2022
Multicenter Validation Study to Implement Plasma Epidermal Growth Factor Receptor T790M Testing in Clinical LaboratoriesNatasha B Leighl, Suzanne Kamel-Reid, Parneet K Cheema, et al.NPJ Precision Oncology|March 25, 2023
Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy durationErica S Tsang, Veronika Csizmok, Laura M Williamson, et al.The Oncologist|May 9, 2014
Diagnostic value of next-generation sequencing in an unusual sphenoid tumorFarzad Jamshidi, Erin Pleasance, Yvonne Li, et al.Pageof 12